Cargando…

Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs

New antithrombotic medications with less effect on haemostasis are needed for the long-term treatment of acute coronary syndromes (ACS). The platelet receptor glycoprotein VI (GPVI) is critical in atherothrombosis, mediating platelet activation at atherosclerotic plaque. The inhibition of spleen tyr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harbi, Maan H., Smith, Christopher W., Alenazy, Fawaz O., Nicolson, Phillip L. R., Tiwari, Alok, Watson, Steve P., Thomas, Mark R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266367/ https://www.ncbi.nlm.nih.gov/pubmed/35805988 http://dx.doi.org/10.3390/ijms23136982

Ejemplares similares

Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib
por: Cooper, Nichola, et al.
Publicado: (2021)

Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010)

Antiplatelet drugs block platelet activation by VITT patient serum
por: Smith, Christopher W., et al.
Publicado: (2021)

Antithrombotic and Antiplatelet Effects of Cordyceps militaris
por: Choi, Eunhyun, et al.
Publicado: (2020)

Antiplatelet and antithrombotic effect of Phyllostachys pubescens leaves and Mume Fructus combination
por: Jin, Wen Yi, et al.
Publicado: (2013)

Antiplatelet, Antithrombotic, and Fibrinolytic Activities of Campomanesia xanthocarpa
por: Klafke, Jonatas Zeni, et al.
Publicado: (2012)

Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo
por: Ku, Sae-Kwang, et al.
Publicado: (2014)

Antithrombotic and antiplatelet activities of Soshiho-tang extract
por: Lee, Jung-Jin, et al.
Publicado: (2013)

Antiplatelet and Antithrombotic Effects of Epimedium koreanum Nakai
por: Irfan, Muhammad, et al.
Publicado: (2021)

Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
por: Srivastava, Padma
Publicado: (2010)

Antiplatelet and Antithrombotic Effects of the Extract of Lindera obtusiloba Leaves
por: Kim, Jun Ho, et al.
Publicado: (2016)

Antiplatelets/antithrombotics: Spontaneous intracerebral haemorrhage: case report
Publicado: (2021)

Mauritia flexuosa Presents In Vitro and In Vivo Antiplatelet and Antithrombotic Activities
por: Fuentes, Eduardo, et al.
Publicado: (2013)

Antiplatelet and Antithrombotic Activity of a Traditional Medicine, Hwangryunhaedok-Tang
por: Kim, Kyungho, et al.
Publicado: (2019)

The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity
por: Smith, Christopher W., et al.
Publicado: (2022)

Prevention of fostamatinib-induced blood pressure elevation by antihypertensive agents
por: Lengel, Dave, et al.
Publicado: (2015)

Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia
por: Boccia, Ralph, et al.
Publicado: (2020)

Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs
por: Stephens, Gillian, et al.
Publicado: (2012)

Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit
por: Chelucci, Rafael Consolin, et al.
Publicado: (2014)

Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA
por: McKeage, Kate, et al.
Publicado: (2018)

Clinical Pharmacokinetics and Pharmacodynamics of Fostamatinib and Its Active Moiety R406
por: Matsukane, Ryosuke, et al.
Publicado: (2022)

Two Refractory Immune Thrombocytopenia Case Reports Showing Responsiveness to Fostamatinib
por: Innao, Vanessa, et al.
Publicado: (2023)

Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?
por: Saha, Sovan, et al.
Publicado: (2022)

Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration
por: Wang, Mingyao, et al.
Publicado: (2022)

Antithrombotic and antiplatelet activities of small-molecule alkaloids from Scolopendra subspinipes mutilans
por: Lee, Wonhwa, et al.
Publicado: (2016)

Comparative antiplatelet and antithrombotic effects of red ginseng and fermented red ginseng extracts
por: Irfan, Muhammad, et al.
Publicado: (2022)

Correction to: Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA
por: McKeage, Kate, et al.
Publicado: (2018)

P1614: TAPERING SCHEME AND SUSTAINED RESPONSE IN PATIENTS WITH ITP TREATED WITH FOSTAMATINIB
por: Mingot-Castellano, María Eva, et al.
Publicado: (2023)

Synthesis and Antiplatelet Activity of Antithrombotic Thiourea Compounds: Biological and Structure-Activity Relationship Studies
por: Lourenço, André Luiz, et al.
Publicado: (2015)

The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects
por: Stainer, Alexander R., et al.
Publicado: (2019)

561. Phase 3 Trial of Fostamatinib for the Treatment of COVID-19: Repurposing an Immunomodulatory Drug Previously Approved for Immune Thrombocytopenia
por: Mallat, Ziad, et al.
Publicado: (2021)

Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury
por: Tabassum, Neha, et al.
Publicado: (2020)

The Cardiovascular Risks of Fostamatinib in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Chen, Yuehong, et al.
Publicado: (2021)

Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion
por: Lucchesi, Alessandro, et al.
Publicado: (2023)

Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies
por: Handoyo, Victoria, et al.
Publicado: (2019)

Synthesis and Assessment of Antiplatelet and Antithrombotic Activity of 4-Amino-Substituted 5-Oxoproline Amides and Peptides
por: Krasnov, Victor P., et al.
Publicado: (2023)

Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic
por: Strich, Jeffrey R, et al.
Publicado: (2020)

Newer antithrombotic drugs
por: Sikka, Pranav, et al.
Publicado: (2010)

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms
por: De Stefano, Valerio, et al.
Publicado: (2018)

Transitioning From Thrombopoietin Agonists to the Novel SYK Inhibitor Fostamatinib: A Multicenter, Real-World Case Series
por: Hughes, David M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67lvqbj7lqnbkov0gnc8lrafgi